Clinical Trials Browser

Phase 1/2 × Leukemia, Prolymphocytic × Filgrastim × Clear all

NCT01629511 2020-02-24

Allogeneic Stem Cell Transplant for CLL

Phase 1/2 Terminated

15 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic